Human nuclear receptor superfamily has 48 members, among which the androgen receptor (AR), the estrogen receptor (ER), the progesterone receptor, the glucocorticoid receptor (GR), and the mineralocorticoid receptor (MR) belong to the steroid receptor family. 12 The transcriptional activity of steroid receptors is mainly regulated by ligand; however, post-translational modifications, such as phosphorylation, acetylation, ubiquitylation, and sumoylation, also 
H istone deacetylase inhibitors (HDACi) have exhibited antifibrotic, anti-inflammatory, antihypertrophic, and antihypertensive effects. 1, 2 HDACs are widely implicated in production of inactive heterochromatin through deacetylation of localized chromatins. 3 Most genes localized in heterochromatins are inactivated in terms of expression. 3, 4 However, recent studies have reported that many genes are repressed by HDACi, 5, 6 suggesting a more complex function of HDACs in regulation of gene expression. HDACi, which causes hyperacetylation on chromatin, represses gene expression in spite of activated promoters, 7 indicating that HDACi affects acetylation of nonhistone proteins such as transcription factors.
Direct acetylation of transcription factors results in either inhibition 8 or activation 9 of gene expression. Several studies have reported that some HDACs act as a coactivator of transcription factors, including nuclear receptors.
play an important role in their stabilization, nuclear translocation, or transcriptional activity. 13 The post-translational modifications of estrogen receptor and AR, which regulate transcriptional activity, have been well investigated in breast cancer and prostate cancer, respectively, whereas that of MR is not known.
14 Aldosterone (Aldo), a mineralocorticoid, is one of the final effectors of the renin-angiotensin-aldosterone system and mediates genomic and nongenomic effects of MR. Aldo is a regulator of blood volume and pressure by handling sodium and potassium homeostasis. Up to 15% of patients with essential hypertension have inappropriate regulation of Aldo. 15 MR modulates kidney function through induction of oxidative stress, as well as expression of epithelial Na + channel, Na + -K + -ATPase subunit α1 (ATP1a1), glucocorticoid-induced leucine zipper (GILZ), and serum and glucocorticoid-regulated kinase 1 (SGK-1). Epithelial Na + channel and ATP1a1 are major Na + -transporting proteins whose expression and activities are regulated in the kidneys by mediators such as GILZ and SGK-1. 16 MR can also induce extracellular matrix proteins, such as collagen I, III, and IV and proinflammatory factors, including intercellular adhesion molecule, monocyte chemoattractant protein, cytokines, and cyclooxygenase-2 in cardiac and renal tissues. 17, 18 Therefore, MR is a potential target of hypertension, hypertrophy, inflammation, and fibrosis. All of the above pathological conditions are effectively attenuated by HDACi; 1, 2, 19 however, the molecular mechanisms are still unclear.
We hypothesized that HDACi attenuates transcriptional activity of MR through its acetylation and prevents development of hypertension in deoxycorticosterone acetate (DOCA)-induced hypertensive rats. In addition, certain HDAC is responsible for MR deacetylation, which is critical for transcriptional activity of MR.
Methods
An expanded Methods section is available in the online Data Supplement.
Animals
The investigation was conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and was approved by the institutional review board of Kyungpook National University School of Medicine, and every effort was made to minimize both the number of animals used and their suffering. Sixteen-week-old male Sprague-Dawley rats were unilaterally nephrectomized under ketamine (150 mg/kg, Yuhan, Seoul, Korea) and xylazine (18 mg/kg; Bayer, Seoul, Korea) anesthesia. After unilateral nephrectomy, rats were allowed to recover overnight before being randomly assigned to one of 3 groups: control (n=4), DOCA-salt (n=4), and DOCA-salt plus valproic acid (VPA; n=4). DOCA-salt was injected subcutaneously at 40 mg/kg per week for a period of 4 weeks. The animals had free access to 1% NaCl with or without 0.71% VPA.
Statistics
Results are expressed as mean±SE. Kruskal-Wallis test and 1-way ANOVA followed by post hoc Tukey's comparison test were used for analysis of data; differences were considered significant at P<0.05. The Student t test was applied for analysis of significant differences 
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Results
HDACi
VPA Had Little Effect on MR Translocation but Increased MR Acetylation
Live cell imaging was performed for visualization of nuclear translocation of MR. The green fluorescent protein (GFP)-tagged MR was traced by fluorescence microscopy every 10 
Transcriptional Activity of MR Was Decreased by Acetylation
The luciferase assay was used for evaluation of promoter activity in response to Aldo. The ATP1a1 promoter was fused with the pA3luc vector and induced by Aldo. Treatment with Aldo resulted in profound induction of promoter activity, which was significantly decreased by pretreatment with VPA (P<0.05) only when HEK293 cells were transfected with wild-type MR ( Figure 4A ). Using a site-directed mutagenesis kit, 2 lysines in the hinge region of MR were substituted with alanine or arginine ( Figure  4B ). Aldo also induced ATP1a1 promoter-fused pA3luc vector in HEK293 cells transfected with mutant MR in which VPA did not inhibit transcriptional activity induced by Aldo ( Figure 4A ). Mutation of MR resulted in significantly decreased MR acetylation even after pretreatment with VPA, followed by stimulation with Aldo, compared with wild-type MR ( Figure 4C ). MS-275 showed similar effect on transcriptional activities of wild-type and mutant MR (Online Figure IIIC) .
HDAC3 Enhanced Transcriptional Activity of MR
VPA primarily inhibits HDAC class I (1, 2, 3, and 8) and class IIa (4, 5, and 7). 20 We investigated interaction between MR and HDAC class I because class I HDACs are mainly located in the nucleus. 21 Co-immunoprecipitation data showed that MR interacts with HDAC3 regardless of Aldo treatment ( Figure  5A ). MR was enriched in the nucleus after Aldo stimulation ( Figure 5A, input, upper) , whereas HDAC protein in the nucleus was not changed by Aldo treatment ( Figure 5A , input, lower). Treatment with Aldo resulted in reduced interaction among HDAC3, MR, and nuclear receptor corepressor. Pretreatment with VPA resulted in almost complete blockade of the interactions of these proteins ( Figure 5B ). Knockdown of HDAC3 by siRNA resulted in increased acetylation of MR ( Figure 5C ), leading to decreased expression of MR target genes, including GILZ ( Figure 5D ) and SGK-1 ( Figure 5E ) induced by Aldo.
VPA Attenuated DOCA-Salt-Induced Hypertension and MR Target Gene Expression
Using the tail-cuff method, systolic blood pressure was measured and recorded for 4 weeks. Unilateral nephrectomy followed by administration of 1% NaCl had little effect on systolic blood pressure. Addition of DOCA-salt infusion resulted in significantly increased systolic blood pressure after 3 weeks (P<0.05 versus vehicle), which was abrogated by Figure 6 . Effect of valproic acid (VPA) administration on blood pressure, body weight, and mineralocorticoid receptor (MR) target gene expression in deoxycorticosterone acetate (DOCA)-salt-induced hypertensive rats. A, Blood pressures were measured using the tail-cuff method in the vehicle group (n=4), DOCA-salt infusion group (n=4), and DOCA-salt infusion and VPA administration group (n=4) for a period of 4 weeks. Administration of VPA resulted in restoration of DOCA-salt-induced hypertension (*P<0.05 vs vehicle). B, Body weights were monitored for 4 weeks. DOCA-salt infusion with or without VPA administration did not have an effect on body weight gain. DOCA-salt infusion resulted in increased gene expression of ATP1a1 (C), GILZ (D), and SGK-1 (E) in rat kidneys, which was attenuated by VPA administration (*P<0.05, **P<0.01 vs vehicle, and #P<0.05 vs DOCA group).
administration of VPA ( Figure 6A ). Neither DOCA-salt infusion nor VPA administration affected gain of body weight ( Figure 6B ). We analyzed expression of 3 major MR target genes, ATP1a1, GILZ, and SGK-1, in the kidney. DOCAsalt infusion resulted in profoundly induced expression of ATP1a1 ( Figure 6C ; P<0.05 versus vehicle), GILZ ( Figure  6D ; P<0.05 versus vehicle), and SGK-1 ( Figure 6E ; P<0.01 versus vehicle), which was attenuated by administration of VPA (Figure 1C-1E ; P<0.05 versus DOCA-salt infusion group).
VPA Attenuated Enrichment of MR and Pol II on Target Gene Promoters Induced by DOCA In Vivo
The GREs in the promoter of rat GILZ were searched by chromatin immunoprecipitation scanning in rats. 22 Two GRE sequences (−2370/−2355 and −1873/-1853) were found in the GILZ proximal promoter from transcription start site to −5 kb upstream ( Figure 7A, upper) . Infusion of DOCA salt resulted in enrichment of MR and Pol II on a GRE in the GILZ proximal promoter, which was attenuated by administration of VPA (P<0.01) ( Figure 7A, lower) . Infusion of DOCA salt also resulted in enrichment of MR (P<0.05 versus vehicle) and Pol II (P<0.01 versus vehicle) on a GRE in the SGK-1 promoter, which was attenuated by administration of VPA (P<0.05; Figure 7B ).
Discussion
Results of the current study demonstrate that HDACi attenuates transcriptional activities of MR in vitro and in vivo. HDACi increases MR acetylation, which reduces transcriptional activity of MR and prevents development of hypertension. Among the HDAC class I, HDAC3 catalyzes MR deacetylation, which restores transcriptional activity of MR.
HDACs are known to play an important role in remodeling of chromatin structures. HDAC induces hypoacetylation of localized chromatin domain, which widely participates in gene repression/silencing. 3 Intriguingly, the ability of several HDACs and histone acetyltransferases (HATs) to deacetylate and acetylate nonhistone protein substrates (eg, transcription factors), respectively, has been demonstrated, suggesting the possibility that protein acetylation provides a rapid and reversible regulatory mechanism like protein phosphorylation. 23 HDACs and HATs maintain a relative balance in a normal physiological condition. However, HDAC activity is elevated in pathological conditions, including hypertension.
2 Although HDACs have long been known as corepressors, recent study has shown that HDAC serves as a coactivator of GR. 10 Acetylation of lysine at a specific motif (KTKK) in the hinge region of GR by circadian locomotor output cycles kaput/brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1 (BMAL1) complex resulted in repression of transcriptional activity of GR. 24 Similar to this result, treatment with HDACi resulted in increased acetylation of MR in HEK293 cells (Figure 3C and 3D; Online Figure IIIA and IIIB) and kidneys of DOCAsalt-induced hypertensive rats (Online Figure VIB) . Point mutations of 2 lysines in the hinge region of MR attenuated the HDACi effect, which repressed transcriptional activity of MR ( Figure 4A ; Online Figure IIIC) . HDACi reduces expression of extracellular matrix protein, such as collagen and inflammatory markers, including several interleukins, tumor necrosis factor, and nuclear factor κB in spontaneously hypertensive rats 2 and DOCA-salt-induced hypertensive rats. IA-IC). VPA would likely upregulate MR corepressors which downregulate expression of the MR target gene. However, administration of VPA had little effect on expression of MR corepressor genes, compared with those of the DOCAsalt-infused group (Online Figure V) . In accordance with our results, a decrease of some MR corepressor genes was observed in patients with Aldo-producing adenoma. 25 Of particular interest, expression of renin-and angiotensinconverting enzyme (ACE) was suppressed in the kidneys of DOCA-salt-induced hypertensive rats, which was restored by administration of VPA (Online Figure IV) . It seems that expression of renin and ACE is negatively regulated by the level of blood pressure. Although we did not define the molecular mechanisms, some epigenetic mechanisms, such as chromatin remodeling, may induce ACE expression. Our previous study demonstrated that ACE expression is regulated by histone code modifications. 26 Treatment of HDACi resulted in decreased recruitment of wild-type MR and Pol II on the promoters of target genes in vitro ( Figure 2 ) and in vivo (Figure 7 ). Although the recruitment of mutant MR on the promoters of target genes was increased by Aldo, HDACi showed little effect on the recruitment (Online Figure II) . Ligand-bound MR translocates into the nucleus to act as a transcription factor by binding to specific hormone-responsive elements in target genes, which are potentially located up to 10 kb upstream or downstream from transcription start site. 22, 27 Hormone-bound receptor recruits the coactivator complex, which facilitates target gene transcription by recruitment of RNA polymerase. 28 Several studies have reported that, among the components of MR coactivator complex, steroid receptor coactivator-1 and p300/ CBP, which belong to the HAT families, play a crucial role in ligand-bound MR activity. 29, 30 Up to date, little is known about how MR acetylation regulates its transcriptional activity. We suggest that HDAC enforces transcriptional activity of MR in hyperaldosteronism-induced hypertension because HDACi ameliorates the actions of mineralocorticoid. Among the class I HDAC, HDAC3 is responsible for regulation of MR transcriptional activity because MR interacted with only HDAC3, of which knockdown resulted in increased MR acetylation and suppressed expression of MR target genes ( Figure 5 ). Some steroid hormone receptors are known to regulate their activity by acetylation. Elimination of acetylation showed strong AR activity on the promoter of prostatespecific antigen, but not of the Pem homeodomain gene; therefore, the effect of acetylation on AR is promoterspecific. 31 Acetylation of estrogen receptor-α normally results in suppression of ligand sensitivity, which is revealed by mutation of lysine residues 302 or 303 to arginine. 32, 33 Progesterone receptor hinge region regulates the kinetics of nuclear translocation and transcriptional responses of progesterone receptor through acetylation and phosphorylation. 34 Acetylation by circadian locomotor output cycles kaput/BMAL1 in the hinge region of GR results in reduced transcriptional activity. 24 However, acetylation of MR and its effect on physiology are unknown. Potential consensus sequences of acetylation in the MR hinge region are found in several species, including human and rat ( Figure 4B ). Treatment of HDACi resulted in increased acetylation of MR in HEK293 cells (Figure 3C and 3D; Online Figure IIIA and IIIB) and the kidneys of DOCA-salt-induced hypertensive rat (Online Figure VI) . Inhibition or knockdown of HDAC3 resulted in decreased transcriptional activity of MR. Point mutations of lysines in the hinge region of MR attenuated the effect of HDACi in decreasing transeriptional activity of MR (Figure 4) . Together with the above results, we suggest that HDAC3 increases the transcriptional activity of MR by deacetylation in the hinge region of MR, as summarized in Figure 8 .
MR expression has been reported in many tissues, both epithelial and nonepithelial tissues. In epithelial tissues, such as kidney and colon, MR regulates salt balance and water homeostasis through induction of specific ion channels and transporters, for example, epithelial Na+ channel and ATP1a1, as well as specific mediators, including GILZ and SGK-1. 16 Aldo and DOCA significantly induced ATP1a1, GILZ, and SGK-1 in vitro ( Figure 1 ) and in vivo ( Figure  6C-6E ), respectively. Owing to abundant expression of 11βHSD2, which catalyzes active cortisol to inactive cortisone, kidney and colon tissues are highly sensitive to mineralocorticoid. 35 The discovery of new sites of MR expression in nonepithelial tissues, such as the heart, vasculature, brain, and adipocytes, has led to identification of novel MR target genes with unexpected biological functions in the tissues. 16 For example, in aortic endothelial cells, treatment with Aldo has been shown to result in increased ACE expression, which may be involved in the development of endothelial dysfunction, elevated blood pressure, and vascular injury induced by this steroid. 36 In addition, the adverse effects of Aldo are increments of proinflammatory molecules, extracellular matrix protein, and reactive oxygen species in nonepithelial tissues. 16 The Randomized Aldactone Evaluation Study showed 30% reduction in mortality and 35% reduction in morbidity with low-dose spironolactone in patients with severe heart failure. 37 The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study showed substantial improvements in patient outcomes with eplerenone after myocardial infarction with systolic dysfunction. 38 Moreover, a blockade of MR receptor improves the clinical outcomes of proteinuric kidney diseases. 39 It is speculated that HDACi or combination with MR antagonist would be one of new strategies for treating cardiovascular disease.
In summary, the present study reveals one of the mechanisms that HDACi attenuates transcriptional activity of MR through increasing its acetylation. MR acetylation reduced hormone-responsive element binding affinity, RNA polymerase recruitment, and expression of target genes, which regulate intracellular salt balance. HDAC3 enhances MR activity via deacetylating in the hinge region of MR. Although exact mechanism of HDACi for treating cardiovascular disease remains elusive, HDAC is a potential target of metabolic disorder-associated diseases, including hypertension.
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